# Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head

> **NCT00490360** · PHASE2 · COMPLETED · sponsor: **University of Zurich** · enrollment: 2007 (actual)

## Conditions studied

- Cancer of the Pancreatic Head

## Interventions

- **DRUG:** Gemcitabine / Cisplatin

## Key facts

- **NCT ID:** NCT00490360
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 2007 (ACTUAL)
- **Last updated:** 2007-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00490360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00490360, "Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00490360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*